Subscribe to:
Post Comments (Atom)
CHECKMATE 067 update
Last weekend, we also got the 3 year- update on CHECKMATE 067 the Ipi vs Nivo vs Ipi+Nivo study- the one that we don't like as underp...

-
QuickStart to Melanoma at ESMO for Melanoma advocates! Program and registration here
-
And the session that we all have been waiting for is about to start: adjuvant therapies in Melanoma- so for patients with Stage 3 Melanoma!...
-
BRIM8: A phase III, randomized, double-blind, placebo-controlled study of vemurafenib adjuvant therapy in patients with surgicall...
No comments:
Post a Comment